Patient Guide: LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 145 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07186101
Status: NOT_YET_RECRUITING
Condition: Ulcerative Colitis
Phase: PHASE2

Where You Can Participate

This study is available at 145 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Anaheim, California
  • • Lancaster, California
  • • And 142 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: - Join Clinical Trial NCTNCT07186101

How to Join This Clinical Trial - NCTNCT07186101

Learn how to participate in this PHASE2 trial studying an investigational therapy for Ulcerative Colitis. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Ulcerative Colitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Ulcerative Colitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07186101 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 145 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85259 - United States

Status: Contact for availability

Clinical Research Site

Anaheim, California 92805 - United States

Status: Contact for availability

Clinical Research Site

Lancaster, California 93534 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90035 - United States

Status: Contact for availability

Clinical Research Site

Colorado Springs, Colorado 80907 - United States

Status: Contact for availability

Clinical Research Site

Hialeah, Florida 33016 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: Contact for availability

Clinical Research Site

Kissimmee, Florida 34741 - United States

Status: Contact for availability

Clinical Research Site

Lakewood Rch, Florida 34211 - United States

Status: Contact for availability

Clinical Research Site

Lighthouse PT, Florida 33064 - United States

Status: Contact for availability

And 135 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Ulcerative Colitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships